Stockreport

Aligos Therapeutics to Announce 4th Quarter 2023 Financial Results on March 12, 2024 [Yahoo! Finance]

Aligos Therapeutics, Inc. - Common stock  (ALGS) 
PDF company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced that it will report the Company's fourth qua [Read more]